NLS Pharmaceutics AG (NLSP) — Financial Flexibility Index
NLS Pharmaceutics AG (NLSP) has a Financial Flexibility Index of -1.43x as of September 2025. Free cash flow of $-2.07 Million (operating CF $-2.07 Million minus capex $0.00) represents -1% of total liabilities ($1.46 Million). Check how strategically is NLS Pharmaceutics AG's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NLS Pharmaceutics AG Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for NLS Pharmaceutics AG across 8 annual periods. See NLS Pharmaceutics AG short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for NLS Pharmaceutics AG (2017–2024)
Year-by-year free cash flow to debt coverage for NLS Pharmaceutics AG. For the full company profile including market capitalisation, see NLSP stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -5.16x | $-4.26 Million | $-4.27 Million | $826.76K | ▼ -468.8% |
| 2023 | -0.91x | $-9.68 Million | $-9.68 Million | $10.68 Million | ▲ +60.8% |
| 2022 | -2.31x | $-13.88 Million | $-13.88 Million | $6.00 Million | ▲ +18.8% |
| 2021 | -2.85x | $-14.90 Million | $-14.94 Million | $5.22 Million | ▼ -3887.3% |
| 2020 | -0.07x | $-729.38K | $-729.39K | $10.20 Million | ▼ -226.5% |
| 2019 | -0.02x | $-150.45K | $-190.01K | $6.87 Million | ▲ +92.7% |
| 2018 | -0.30x | $-2.69 Million | $-2.73 Million | $8.96 Million | ▲ +44.6% |
| 2017 | -0.54x | $-5.43 Million | $-5.43 Million | $10.01 Million | — |